ARCHIVES

In Brief: James Wallace Named CALGB Executive Officer; Gritz Receives First Joseph Cullen Award

This article is from The Cancer Letter archive.

Vol. 18 No. 35 | September 11, 1992

Download PDF Visit The Full Archive

Related Articles

Fox Chase Symposium Tro Focus On Year 2000 Goals

August 21, 1987

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013

Congressman Obey Attacks NCI for Not Supporting Basic Research

January 23, 1976

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

February 9, 1990

Cancer Informatics: NCI Calls On Users To Help Redesign Physician’s Data Query

February 13, 1998